⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12834886 | 0.82 | — | — | |
| SCHEMBL28342686 | 0.82 | TSHR (0.48) | — | |
| SCHEMBL7719659 | 0.78 | CES2 (0.45) | — | |
| SCHEMBL35853 | 0.78 | NOS3 (0.46) | — | |
| SCHEMBL6959784 | 0.75 | — | — | |
| SCHEMBL6965957 | 0.75 | — | — | |
| SCHEMBL10915594 | 0.75 | — | — | |
| SCHEMBL2029533 | 0.73 | — | — | |
| SCHEMBL801912 | 0.73 | NOS3 (0.48) | — | |
| SCHEMBL7303988 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912594-B2 | Carbon disulfide-modified amine additives for separation of oil from water | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2024-02-27 | — | — | US | disclosed |
| EP-3243909-B1 | METHODS FOR PERFORMING HYBRIDIZATIONS WITH SEPARATE DENATURATION OF THE SAMPLE AND PROBE | AGILENT TECHNOLOGIES INC (US) | 2020-09-02 | — | — | EP | disclosed |
| EP-2285979-B2 | HYBRIDIZATION COMPOSITIONS AND METHODS | DAKO DENMARK AS (DK) | 2020-02-19 | — | — | EP | disclosed |
| US-8993697-B2 | Conducting and semiconducting organic materials | Commonwealth Scientific and Industrial Research Institute Organisation (AU) | 2015-03-31 | — | — | US | disclosed |
| US-20130289217-A1 | CONDUCTING AND SEMICONDUCTING ORGANIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-10-31 | — | — | US | disclosed |
| US-8501889-B2 | Conducting and semiconducting organic materials | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-08-06 | — | — | US | disclosed |
| US-8372860-B2 | Carboline derivatives useful in the inhibition of angiogenesis | PTC THERAPEUTICS, INC. (US) | 2013-02-12 | — | — | US | disclosed |
| US-8372860-B2 | Carboline derivatives useful in the inhibition of angiogenesis | PTC THERAPEUTICS, INC. (US) | 2013-02-12 | — | — | US | disclosed |
| US-20110166298-A1 | CONDUCTING AND SEMICONDUCTING ORGANIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL ORGANISATION (AU) | 2011-07-07 | — | — | US | disclosed |
| US-20100179132-A1 | CARBOLINE DERIVATIVES USEFUL IN THE INHIBITION OF ANGIOGENESIS | PTC THERAPEUTICS, INC. | 2010-07-15 | — | — | US | disclosed |
| US-20100179132-A1 | CARBOLINE DERIVATIVES USEFUL IN THE INHIBITION OF ANGIOGENESIS | PTC THERAPEUTICS, INC. | 2010-07-15 | — | — | US | disclosed |
| US-20100158858-A1 | ADMINISTRATION OF CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISEASES | PTC THERAPEUTICS, INC. | 2010-06-24 | — | — | US | disclosed |
| US-7601840-B2 | Carboline derivatives useful in the inhibition of angiogenesis | PTC THERAPEUTICS, INC. (US) | 2009-10-13 | — | — | US | disclosed |
| US-20090023928-A1 | PHTHALAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS | THE REGENTS OF THE UNIVERISTY OF CALIFORNIA (US) | 2009-01-22 | — | — | US | disclosed |
| US-20070281962-A2 | Administering 1,2,3,6-tetrasubstituted pyrido[3,4-b]indoles to inhibit the 5'-untranslated region-dependent translation; anticarcinogenic agents; retinopathy, rheumatoid arthritis, psoriasis, atherosclerosis, obesity, macular degeneration | PCT THERAPEUTICS, INC. (US) | 2007-12-06 | — | — | US | disclosed |